Block copolymer and antithrombotic coating agent

US9474835B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9474835-B2
Application numberUS-201214237664-A
CountryUS
Kind codeB2
Filing dateAug 10, 2012
Priority dateAug 15, 2011
Publication dateOct 25, 2016
Grant dateOct 25, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The object of the present invention is achieved by providing a copolymer, in particular, a block copolymer which has excellent coating formation ability, adhesive properties to a substrate, and does not adsorb protein; an antithrombotic coating agent which has superior antithrombotic properties and adhesive properties to a substrate to those of the conventional antithrombotic coating agent; and a medical instrument which is obtained by coating the antithrombotic coating agent, and the block copolymer includes a polymer (A) containing a (meth)acrylic ester monomer and a polymer (B) containing a (meth)acrylamide monomer and has excellent coating formation ability and high adhesive properties to a substrate.

First claim

Opening claim text (preview).

The invention claimed is: 1. A triblock type copolymer including a polymer (A) containing a monomer (a) represented by the general formula (1) and a polymer (B) containing a monomer (b) represented by the following formula (2): in the formulae (1) and (2), R 0 represents an alkyl group having 1 to 3 carbon atoms; R 1 represents a hydrogen atom, or a methyl group; R 2 represents an alkylene group having 2 or 3 carbon atoms; R 3 , and R 4 represent a hydrogen atom, or an alkyl group having 1 or 2 carbon atoms; and n represents an integer from 1 to 9, wherein the triblock type copolymer is A-B-A type or A-B*-A type; and the copolymer B* contains the monomer (a) represented by the general formula (1) and the monomer (b) represented by the general formula (2). 2. The triblock type copolymer according to claim 1 , wherein the molar ratio (A:B) between the polymer (A) and the polymer (B) is in a range from 1:50 to 50:1. 3. The triblock type copolymer according to claim 1 , wherein the polymer (B*) is a copolymer including the monomers (b) and (a), and the molar ratio ((b):(a)) between the monomer (b) and the monomer (a) in the polymer (B) is in a range from 99:1 to 10:90. 4. The triblock type copolymer according to claim 1 , wherein the polymerization degree of the polymer (A) is in a range from 30 to 3,000, and the polymerization degree of the polymer (B) is in a range from 20 to 20,000. 5. A coating film containing a triblock type copolymer including a polymer (A) containing a monomer (a) represented by the general formula (1) and a polymer (B) containing a monomer (b) represented by the following formula (2): wherein in the formulae (1) and (2), R 0 represents an alkyl group having 1 to 3 carbon atoms; R 1 represents a hydrogen atom, or a methyl group; R 2 represents an alkylene group having 2 or 3 carbon atoms; R 3 , and R 4 represent a hydrogen atom, or an alkyl group having 1 or 2 carbon atoms; and n represents an integer from 1 to 9, wherein the triblock type copolymer is A-B-A type or A-B*-A type; and the copolymer B* contains the monomer (a) represented by the general formula (1) and the monomer (b) represented by the general formula (2). 6. A protein adsorption inhibitor using the coating film according to claim 5 . 7. A cell culture substrate using the coating film according to claim 5 . 8. An antithrombotic coating agent including a triblock type copolymer that includes a polymer (A) containing a monomer (a) represented by the general formula (8), and a polymer (B) containing a monomer (b) represented by the following formula (9): in the formula (8), R 1 represents a hydrogen atom or a methyl group; R 2 represents an alkylene group having 2 or 3 carbon atoms; and R 3 represents an alkyl group having 1 to 3 carbon atoms: in the formula (9), R 1 represents a hydrogen atom, or a methyl group; R 3 , and R 4 , represent a hydrogen atom, or an alkyl group having 1 or 2 carbon atoms, wherein the triblock type copolymer is A-B-A type or A-B*-A type; and the copolymer B* contains the monomer (a) represented by the general formula (8) and the monomer (b) represented by the general formula (9). 9. The antithrombotic coating agent according to claim 8 , wherein the polymer (A) is not dissolved in water, and the polymer (B) or the copolymer (B*) is dissolved in water. 10. The antithrombotic coating agent according to claim 8 , wherein the molar ratio (monomer (b)/monomer (a)) between the monomer (b) and the monomer (a) is in a range of 99/1 to 10/90. 11. The antithrombotic coating agent according to claim 8 , wherein the molar ratio (polymer (A)/polymer (B) or polymer (A)/copolymer (B*)) between the polymer (A) and the polymer (B) or the copolymer (B*) is in a range of 1:50 to 50:1. 12. The antithrombotic coating agent according to claim 8 , wherein the polymerization degree of the polymer (A) is in a range of 30 to 3,000, and the polymerization degree of the polymer (B) or the copolymer (B*) is in a range of 20 to 20,000. 13. The antithrombotic coating agent according to claim 8 , wherein the antithrombotic coating agent includes 0.05 to 10 parts by mass of the triblock type copolymer, and 90 to 99.95 parts by mass of a solvent containing any one of ethanol, methanol, and isopropyl alcohol as a main component. 14. A surface-modifying agent for a medical or biochemical instrument comprising the coating film according to claim 5 . 15. The triblock type copolymer according to claim 2 , wherein the polymer (B*) is a copolymer including the monomers (b) and (a), and the molar ratio ((b):(a)) between the monomer (b) and the monomer (a) in the polymer (B) is in a range from 99:1 to 10:90.

Assignees

Inventors

Classifications

  • Homopolymers or copolymers of acrylamide or methacrylamide · CPC title

  • using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent · CPC title

  • Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers · CPC title

  • Acrylamide; Methacrylamide · CPC title

  • Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9474835B2 cover?
The object of the present invention is achieved by providing a copolymer, in particular, a block copolymer which has excellent coating formation ability, adhesive properties to a substrate, and does not adsorb protein; an antithrombotic coating agent which has superior antithrombotic properties and adhesive properties to a substrate to those of the conventional antithrombotic coating agent; and…
Who is the assignee on this patent?
Haraguchi Kazutoshi, Kubota Kazuomi, Takehisa Tooru, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61L33/064. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).